<http://schema.org/description>
"Teva Pharmaceuticals is feverishly working to deflect revenue risk tied to the impending patent expiration for its highly popular multiple sclerosis drug Copaxone. The company&amp;#039;s attempts to"^^<http://www.w3.org/2001/XMLSchema#string>
<http://www.aol.com/article/2014/03/28/supreme-court-ignores-teva-pharmaceuticals-ltds-pl/20859064/>